Leidos announces trading blackout for employee plan

Published 15/05/2025, 21:36
Leidos announces trading blackout for employee plan

Leidos Holdings , Inc. (NYSE:LDOS), a prominent $20.14 billion Professional Services company with a GREAT financial health rating according to InvestingPro, has notified the participants of its Retirement Plan about an upcoming blackout period, according to a recent SEC filing. The blackout, starting in the week of June 29, 2025, and expected to end in the week of July 20, 2025, will temporarily restrict participants from conducting transactions within their plan accounts.

The trading suspension is due to administrative changes, including updates to the plan’s recordkeeper and trustee. During this period, plan participants will not be able to alter contribution rates, direct investments, or diversify their portfolios, which includes investments in Leidos Holdings, Inc. common stock. Additionally, obtaining loans, making withdrawals, or taking distributions from their accounts will be prohibited. The company maintains strong financial stability with a current ratio of 1.54, indicating its ability to meet short-term obligations.

Leidos Holdings, Inc. has also informed its directors and executive officers about the trading restrictions on the company’s common stock that apply to them during the blackout period, as mandated by Section 306 of the Sarbanes-Oxley Act of 2002 and Rule 104 of Regulation BTR. This notice is intended to prevent insider trading during times when employees cannot trade their retirement plan shares.

The company, based in Reston, Virginia, has provided a means for security holders and other interested parties to obtain the exact blackout dates without charge, by contacting the Office of the Corporate Secretary at Leidos Holdings, Inc.’s principal executive office.

This announcement is based on a press release statement.

In other recent news, Leidos Holdings reported impressive financial results for the first quarter of 2025, surpassing analysts’ expectations with an earnings per share (EPS) of $2.97, significantly above the forecast of $2.50. The company also exceeded revenue projections, posting $4.25 billion compared to the anticipated $4.09 billion. Following these strong results, RBC Capital Markets raised its price target for Leidos to $160, while Citi increased its target to $186, maintaining a Buy rating. Leidos’ performance was attributed to growth in its Health & Civil sectors and strength across its portfolio, despite some challenges related to contracting actions by the new administration. The company also announced a pending acquisition in the cybersecurity space, highlighting its strategic focus on expanding capabilities in critical areas. Leidos reaffirmed its full-year guidance for 2025, projecting revenue between $16.9 billion and $17.3 billion, and continues to align its strategic initiatives with governmental priorities. These developments reflect a positive outlook for the company, as noted by analysts at RBC Capital and Citi.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.